Immune checkpoint inhibitor in recurrent hypermutated glioblastoma with POLE mutation

Neurooncol Adv. 2021 Jun 28;3(1):vdab093. doi: 10.1093/noajnl/vdab093. eCollection 2021 Jan-Dec.
No abstract available